A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis

August 20, 2013

This study is currently recruiting participants. Verified December 2012 by Asubio Pharmaceuticals.

Sponsor:

Asubio Pharmaceuticals

Information provided by:

Asubio Pharmaceuticals

ClinicalTrials.gov Identifier:

NCT01756898

Purpose:

The purpose of this research study is to gather scientific information about the effectiveness of the study drug, ASB17061 capsules, when compared to placebo in adult subjects with atopic dermatitis.

Name/Title of the Principal Investigator:

Andrew Racette, DO

Contact Information:

Hope Research Institute
Nicole Miller – Recruitment Coordinator
3900 E. Camelback Road, Ste 185
Phoenix, AZ 85018
Fax Number: 602-288-4678
Business Number: 602-288-4673
Email: recruitment@hriaz.com

For more information, please visit:

www.clinicaltrials.gov

Please click here to return to the Clinical Trials main page